MTOR and breast cancer: Magnoflorine has been shown to activate p38 and inhibit AKT/mTOR signaling pathways to induce autophagy, which further exacerbated doxorubicin-induced apoptosis, thereby increasing the sensitivity of breast cancer cells to doxorubicin [218].